Back
Supernus Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison
Buy
51
SUPN
Supernus Pharmaceuticals
Last Price:
37.75
Seasonality Move:
8.24%
Buy
63
UTHR
United Therapeutics
Last Price:
397.46
Seasonality Move:
4.71%
Buy
51
Supernus Pharmaceuticals (SUPN)
is a Buy
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $37.75. The Score for SUPN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- SUPN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy, Sell or Hold?
- The current United Therapeutics [UTHR] share price is $397.53. The Score for UTHR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $37.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
UTHR Stock Price Chart
What is United Therapeutics's stock price today?
-
The United Therapeutics share price today is $397.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 76.85 | Buy |
| Chaikin Money Flow: | 420499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.37 - 34.89) | Buy |
| Bollinger Bands (100): | (28.44 - 34.28) | Buy |
UTHR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.49 | Buy |
| Relative Strength Index (14 RSI): | 74.85 | Buy |
| Chaikin Money Flow: | 265674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (349.81 - 374.09) | Buy |
| Bollinger Bands (100): | (321.78 - 360.9) | Buy |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.84 | Buy |
| 20-day SMA: | 34 | Buy |
| 50-day SMA: | 33.09 | Buy |
| 200-day SMA: | 30.61 | Buy |
| 8-day EMA: | 35.11 | Buy |
| 20-day EMA: | 34.16 | Buy |
| 50-day EMA: | 33.11 | Buy |
| 200-day EMA: | 31.13 | Buy |
UTHR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 371.07 | Buy |
| 20-day SMA: | 364.24 | Buy |
| 50-day SMA: | 356.86 | Buy |
| 200-day SMA: | 291.7 | Buy |
| 8-day EMA: | 376.06 | Buy |
| 20-day EMA: | 366.6 | Buy |
| 50-day EMA: | 355.67 | Buy |
| 200-day EMA: | 307.55 | Buy |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
United Therapeutics Earnings Growth & UTHR Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.
Supernus Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United Therapeutics Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||